Where complex surgical technology becomes ready for clinical practice

When organizations call

Organizations typically reach out when:

A novel or disruptive surgical technology is approaching its first regulatory or clinical inflection point and early decisions will shape everything that follows
Regulatory feedback raises fundamental questions about claims, evidence, or pathway
Evidence plans no longer reflect real surgical practice or procedural variability
Transitioning from controlled settings into routine clinical use introduces new risk
Safety signals prompt questions of responsibility, oversight, or public communication
Leadership or the board needs an independent perspective grounded in regulatory and surgical experience

This work often spans portfolios, helping organizations apply consistent decision frameworks across multiple surgical platforms and technology classes.

Discuss your next 90-day decision